Rationale: Acute exposure to ambient particle matter is associated with increased levels of the cysteinyl leukotriene (CysLT) biomarker, urinary leukotriene E4 (uLTE 4 ), in subjects with asthma.
Methods: Daily concentrations of particulate matter of 2.5 mm and smaller diameter (PM 2.5 ) and repeated measurements of albuterol use over a 5-month period were collected in 44 urban school children with persistent asthma. DNA was analyzed for gene polymorphisms on genes involved in the CysLT pathway to identify gene-environment interactions. An experimental challenge study in 16 adults with mild, nonpersistent asthma was performed to define biological pathways explaining these gene-environment interactions. Subjects in the challenge study were exposed on two different days to filtered air or diesel exhaust (300 mg PM 2.5 /m 3 ). FEV 1 and CysLT-related gene DNA methylation and messenger RNA expression changes were measured before and 6 hours after exposure challenges.
Results: In school children with asthma, associations between PM 2.5 and school-time albuterol usage were significantly greater in those with the variant C allele in the CysLT receptor 1 (CysLTR 1 ) rs320995 locus (5.4% increase per interquartile range PM 2.5 increase) compared with those homozygous for the wild-type T allele (1.6% decrease; P = 0.005 for allele 3 PM 2.5 interaction). In the challenge study, declines in forced expiratory volume in 1 second after diesel exhaust exposure were associated with lower CysLTR 1 expression (r 2 = 0.52; P = 0.01), which, in turn, was associated with decreased leukotriene C4 synthase cg1631890 (P = 0.02) and increased CysLTR 1 cg26848126 (P = 0.01) methylation, as assessed in a multivariable model (r 2 = 0.69). ) mice are susceptible to pulmonary fibrosis.
Conclusions
Objectives: In this study, we hypothesized that Stat1 2/2 mice exhibit a differential fibrogenic response to tangled MWCNTs versus rigid MWCNTs above that seen with wild-type (Stat1 1/1 ) mice.
Methods: Stat1
1/1 and Stat1 2/2 mice were exposed to tangled MWCNTs or rigid MWCNTs (4 mg/kg) via oropharyngeal aspiration, and lung tissues were collected after 1 and 21 days to measure messenger RNA and protein levels of fibrogenic mediators.
Results: Compared with tangled MWCNTs, rigid MWCNTs caused mucous cell metaplasia, epithelial cell proliferation, increased fibrosis, and larger granulomas in the lungs of mice. Both MWCNT types induced acute neutrophilia; however, only rigid MWCNTs induced chronic neutrophilia. Stat1 2/2 mice exhibited higher serum levels of immunoglobin E and even higher levels when treated with rigid MWCNTs. Twenty-one days after treatment with rigid MWCNTs, compared with Stat1 1/1 mice, Stat1 2/2 mice had higher levels of transforming growth factor-b1 (TGF-b1) protein in bronchoalveolar lavage fluid, increased transforming growth factor-b1 signaling activation, and higher airway collagen deposition. Some of the results of this study were previously reported in the form of an abstract and a paper (1, 2).
Conclusions: Our data emphasize that rigid MWCNTs produce much stronger immune and fibrogenic responses than tangled MWCNTs and that these effects are exaggerated by STAT1 deficiency, highlighting the importance of tube rigidity and genetic susceptibility. The mechanism of STAT1 susceptibility to MWCNTs-induced fibrosis appears to be through dysregulated transforming growth factor-b1 production and signaling. Rationale: An unknown number of post-9/11 military deployers to Iraq and Afghanistan have returned with respiratory symptoms and may be at risk for deployment-related distal lung disease, detected only on surgical lung biopsy. We hypothesized that cardiopulmonary exercise testing and lung clearance index scores would differ significantly between deployers with and without biopsy-proven deployment-related distal lung disease.
Deployment-related Lung
Objectives: To assess if there are differences in cardiopulmonary exercise testing and lung clearance index scores between deployers with and without biopsy-proven deployment-related distal lung disease.
Methods:
We compared 36 deployers with definite deploymentrelated distal lung disease (based on surgical lung biopsy findings of bronchiolitis, granulomatous pneumonitis, and/or emphysema) with 26 deployers without definite deployment-related distal lung disease. We used a two-sample t test assuming unequal variances to compare ventilatory and gas exchange cardiopulmonary exercise testing variables at submaximal and maximal workloads. We then conducted lung clearance index testing in 24 healthy nondeployed control subjects and 28 symptomatic deployers (17 with definite deployment-related distal lung disease), and compared mean lung clearance index scores using adjusted t tests.
Results: At maximum workload, those with definite deploymentrelated distal lung disease had higher respiratory rates and mean measured ratio of minute ventilation to maximal voluntary ventilation greater than 80%, compared with a mean ratio of 69.5% in those without deployment-related distal lung disease. There were no significant differences in cardiopulmonary exercise testing gas exchange parameters. Adjusting for smoking and age, there were differences (P = 0.001) in lung clearance index between deployers (7.76; 95% confidence interval, 7.34-8.17) and control subjects (6.95; 95% confidence interval, 6.73-7.17); but after adjusting for body mass index, differences became insignificant (P = 0.10) between deployers (7.42; 95% confidence interval, 7.13-7.71) and control subjects (7.06; 95% confidence interval, 6.74-7.39).
Conclusions: Increased lung clearance index scores and abnormal exercise ventilatory parameters consistent with small-airway disease show promise as noninvasive diagnostic markers that may help identify symptomatic deployers with deployment-related distal lung disease.
